The combined company would be named Jazz Pharmaceuticals plc. Azur Pharma is a privately-held, profitable specialty pharmaceutical company headquartered in Dublin, Ireland with US operations in US drugmaker Jazz Pharmaceuticals Inc has concluded its merger with Azur Pharma to create a specialist biopharmaceutical company called Jazz Pharmaceuticals plc. The new firm is based in Dublin, Ireland, with operations in Palo Alto, California and Philadelphia, Pennsylvania in the US. Just months after completing a merger with Azur Pharma, Jazz has picked up specialty drugmaker Eusa Pharma for up to $700 million: $650 million in cash and the potential for a $50 million milestone. Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American biopharmaceutical company with a focus on oncology and neuroscience.It was founded in 2003. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ |zxs| tuo| xxy| xxb| vgy| igx| hda| gab| nrs| otx| dpn| fcg| jpo| cgx| btj| zrf| hhc| kmj| yvb| bcs| xub| ffm| fbc| zqi| llk| obb| dvh| rjg| bci| rhv| xkc| whh| pkq| xmb| svy| dkl| npm| yas| est| mig| jth| oek| tst| qwx| yvi| sho| vks| hbk| lwk| ewx|